News Daily News MICHELLE Published: Low-Dose Rivaroxaban Cuts VTE Risk After COVID-19 Admission Todd Neale December 29, 2021
News Daily News Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study Todd Neale December 27, 2021
News Daily News FDA Approves Two Additional Indications for Rivaroxaban in Children L.A. McKeown December 21, 2021
News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Daily News Long-term Anticoagulation After Unprovoked VTE: New Insights Shelley Wood September 13, 2021
News Daily News Therapeutic-Dose Heparin in COVID-19: Who Benefits, Who Doesn’t Shelley Wood August 04, 2021
News Daily News ‘Nontrivial’ Amount of LA Thrombus Found Before AF Procedures Todd Neale June 08, 2021
News Daily News Trials Suggest Need for Prolonged AF Monitoring in More Stroke Patients Todd Neale June 04, 2021
News Daily News Dual Bests Triple Therapy in Nonvalvular AF Patients in RE-DUAL PCI Yael L. Maxwell April 09, 2021
News Daily News Observational Study Supports Continuing Oral Anticoagulation During PCI Michael O'Riordan April 06, 2021
News Daily News Antithrombotic Therapy for COVID-19: Challenges and Lessons for the Future L.A. McKeown March 17, 2021
News Daily News Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis Todd Neale March 02, 2021